multiple sclerosis

Could Celgene Have Another Billion-Dollar Blockbuster on Its Hands?
Motley Fool
Mon, 02/20/17 - 10:04 am
Celgene
ozanimod
MS
multiple sclerosis
Celgene Multiple Sclerosis Pill Succeeds in First Late-Stage Clinical Trial
TheStreet.com
Fri, 02/17/17 - 10:00 am
Celgene
ozanimod
clinical trials
MS
multiple sclerosis
If copies of Teva's Copaxone hit, oral MS rivals could be the real threat
Fierce Pharma
Wed, 02/15/17 - 09:41 am
Teva Pharmaceutical
Copaxone
MS
multiple sclerosis
generics
Tecfidera
Biogen
Gilenya
Novartis
Aubagio
Sanofi
Are Teva Pharmaceutical's Best Days Behind It?
Motley Fool
Wed, 02/1/17 - 05:36 pm
Teva Pharmaceutical
Copaxone
generics
patents
MS
multiple sclerosis
Teva shares fall as court invalidates patent infringement claims
Marketwatch
Mon, 01/30/17 - 10:51 pm
Teva Pharmaceutical
patents
Copaxone
Mylan Labs
multiple sclerosis
MS
Novartis chief Jimenez touts two top PhIII drug prospects
Endpoints
Wed, 01/18/17 - 10:07 am
Novartis
Joe Jimenez
CTL-019
BAF-312
CAR-T
progressive MS
multiple sclerosis
Biogen to pay $1.25B settlement in multiple sclerosis drug case
Bizjournals.com
Tue, 01/17/17 - 11:09 am
Biogen
Tecfidera
Forward Pharma
MS
multiple sclerosis
patents
Roche’s Multiple Sclerosis Drug Shows Positive Results in Several Clinical Trials
Xtalks
Fri, 01/13/17 - 11:20 am
Roche
MS
multiple sclerosis
ocrelizumab
clinical trials
Roche touts efficacy of MS drug despite delays
BioPharma Dive
Tue, 12/27/16 - 10:16 am
Roche
MS
multiple sclerosis
Ocrevus
ocrelizumab
FDA pushes decision on Roche MS drug to March
BioPharma Dive
Wed, 12/21/16 - 11:13 am
FDA
Roche
MS
multiple sclerosis
Ocrevus
ocrelizumab
Biogen recruits Jamie-Lynn Sigler for Tecfidera campaign
Medical Marketing and Media
Wed, 12/14/16 - 09:14 am
Biogen
celebrity endorsements
Tecfidera
MS
multiple sclerosis
Biogen may have edge in high-stakes Tecfidera patent battle, analyst says
Bizjournals.com
Sat, 12/3/16 - 09:24 am
Biogen
Tecfidera
MS
multiple sclerosis
patents
Forward Pharma
Biogen's Tecfidera faces outside pressure
BioPharma Dive
Thu, 12/1/16 - 04:29 pm
Biogen
Tecfidera
multiple sclerosis
MS
patents
Forward Pharma
On the ropes, Opexa shares blasted by PhIIb multiple sclerosis trial flop
Endpoints
Fri, 10/28/16 - 10:08 am
Opexa
multiple sclerosis
MS
clinical trials
Tcelna
Novartis' Is Challenging Biogen on Biogen's Own Turf
Motley Fool
Wed, 10/26/16 - 09:19 pm
Novartis
Biogen
Gilenya
Tecfidera
MS
multiple sclerosis
If Roche's Ocrevus is approved, the already competitive MS market will gain another player
Medical Marketing and Media
Mon, 10/24/16 - 11:54 pm
Roche
Ocrevus
MS
multiple sclerosis
Insurers pay more for multiple sclerosis drug because rebates don’t help, report says
Stat/Pharmalot
Fri, 10/14/16 - 11:29 am
insurers
multiple sclerosis
MS
rebates
Novartis' Multiple Sclerosis Life Cycle Looks More Assured
Seeking Alpha
Tue, 09/20/16 - 09:48 am
Novartis
siponimod
MS
multiple sclerosis
As Tecfidera lags, Biogen hopes real-world data can help keep patients on their meds
Fierce Pharma
Mon, 09/19/16 - 09:54 am
Biogen
Tecfidera
MS
multiple sclerosis
Novartis shows a hole card in a high-stakes PhIII poker game for MS drugs
Endpoints
Sat, 09/17/16 - 01:23 pm
Novartis
MS
multiple sclerosis
siponimod

Pages